Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

about

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

Item

http://www.wikidata.org/entity/Q59055934

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

@en

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

@nl

type

Item

label

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

@en

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

@nl

prefLabel

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

@en

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

@nl

P1476

Fluorine Substituted 1,2,4-Triazinones as Potential Anti-HIV-1 and CDK2 Inhibitors

@en

P2093

Khalid A. Khan

http://www.w3.org/2001/XMLSchema#string

Mohammed S. I. Makki

http://www.w3.org/2001/XMLSchema#string

Reda M. Abdel-Rahman

http://www.w3.org/2001/XMLSchema#string

P2860

Virtual screening of 4-anilinoquinazoline analogues as EGFR kinase inhibitors: importance of hydrogen bonds in the evaluation of poses and scoring functions.

Antiretroviral resistance during successful therapy of HIV type 1 infection.

Fluorine in medicinal chemistry: a century of progress and a 60-year retrospective of selected highlights.

Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era.

Antiviral drugs in current clinical use.

Small molecule inhibitors of the class 1 receptor tyrosine kinase family.

Toxicity of antiretroviral therapy and implications for drug development.

Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome.

4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.

Synthesis and in vitro anticancer and anti-HIV evaluation of new 2-mercaptobenzenesulfonamides.

P304

1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/430573

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime